ClinicalTrials.gov record
Completed Phase 3 Interventional

An Open Label Study of FT218 in Subjects With Narcolepsy

ClinicalTrials.gov ID: NCT04451668

Public ClinicalTrials.gov record NCT04451668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 10:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR

Study identification

NCT ID
NCT04451668
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Avadel
Industry
Enrollment
184 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2020
Primary completion
Dec 21, 2023
Completion
Nov 17, 2024
Last update posted
Oct 1, 2025

2020 – 2024

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Sleep Disorders Center of Alabama Birmingham Alabama 35213
Stanford Sleep Medicine Redwood City California 94063
SDS Clinical Trials Santa Ana California 92705
Alpine Clinical Research Center Boulder Colorado 80301
Delta Waves, Inc. Colorado Springs Colorado 80918
Pulmonary Disease Specialists, PA Kissimmee Florida 34741
Sleep Medicine Specialists of South Florida Miami Florida 33176
FL Pediatric Research Institute Winter Park Florida 32789
NeuroTrials Research Inc Atlanta Georgia 30328
SleepCare Research Institute, Inc. d/b/a Clinical Research Institute Stockbridge Georgia 30281
Fort Wayne Neurological Fort Wayne Indiana 46804
Helene A. Emsellem, MD PC Chevy Chase Maryland 20815
Baystate Medical Center Springfield Massachusetts 01199
St. Luke's Hospital - Sleep Medicine and Research Center Chesterfield Missouri 63017
Montefiore Sleep-Wake Disorders Center The Bronx New York 10467
Advanced Respiratory and Sleep Medicine Huntersville North Carolina 28078
Sleep Management Institute Intrepid Research Cincinnati Ohio 45245
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Ohio Sleep Medicine Institute Dublin Ohio 43017
Geisinger Medical Center Danville Pennsylvania 17822
Brian Abaluck Sleep Medicine Malvern Pennsylvania 19355
Bogan Sleep Consultants, LLC Columbia South Carolina 29201
FutureSearch Trials of Neurology Austin Texas 78731
Sleep Therapy & Research Center San Antonio Texas 78229-4849
Comprehensive Sleep Medicine Associates Sugar Land Texas 77478
Northwest Houston Neurology Tomball Texas 77375
TPMG Clinical Research Williamsburg Williamsburg Virginia 23188

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04451668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04451668 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →